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Abstract 
BACKGROUD & AIMS: To clarify mechanisms involved in the development of 
autoimmune hepatitis (AIH), we recently developed a mouse model of spontaneous 
AIH by inducing a concurrent loss of Foxp3+ regulatory T cells and programmed cell 
death 1 (PD-1)–mediated signaling. Fatal AIH in these mice was characterized by 
severe T-cell infiltration and huge production of anti-nuclear antibodies (Abs). This 
study aims to identify induction sites, responsible T-cell subsets, and key molecules for 
induction of AIH. 
METHODS: To develop the mouse model of AIH, neonatal thymectomy (NTx) was 
performed on PD-1–deficient (PD-1-/-) mice. We then conducted neonatal splenectomy 
or in vivo administration of Abs to cytokines, chemokines, or cell-surface molecules. 
RESULTS: In NTx–PD-1-/- mice, either neonatal splenectomy or in vivo CD4+ T-cell 
depletion suppressed CD4+ and CD8+ T-cell infiltration in the liver. In the induction 
phase of AIH, splenic CD4+ T cells were localized in B-cell follicles with huge 
germinal centers and showed the Bcl6+ICOS+IL-21+IL-21R+ follicular helper T (TFH) 
cell phenotype. Blocking Abs to ICOS or IL-21 suppressed TFH-cell generation and 
induction of AIH. In addition, IL-21 produced by TFH cells drove CD8+ T-cell 
activation. Splenic TFH cells and CD8+ T cells expressed CCR6, and CCL20 expression 
was elevated in the liver. Administration of anti-CCL20 suppressed migration of these 
T cells to the liver and induction of AIH. 
CONCLUSIONS:  Dysregulated TFH cells in the spleen are responsible for the 
induction of fatal AIH, and CCR6-CCL20 axis-dependent migration of splenic T cells is 
crucial to induce AIH in NTx–PD-1-/- mice. 
Keywords: Autoimmune liver disease; pathogenesis; follicular helper T cells 
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Introduction 
 Human autoimmune hepatitis (AIH) shows varied clinical manifestations 
ranging from asymptomatic, mild chronic hepatitis to acute-onset fulminant hepatic 
failure. The histological findings of AIH are characterized by a mononuclear-cell 
infiltration invading the parenchyma, ranging from piecemeal necrosis to submassive 
lobular necrosis.1,2 The serologic hallmark of AIH is the production of a variety of 
characteristic circulating autoantibodies (autoAbs), including anti-nuclear Abs 
(ANAs).1,2 Although AIH appears to be a T-cell mediated autoimmune disease, it is 
unclear which type of effector T cells are involved and how the dysregulated T cells 
trigger the development of AIH. 
 Recently, we developed the first mouse model of spontaneous fatal AIH 
resembling acute-onset AIH presenting as fulminant hepatic failure in humans.3 Neither 
programmed cell death 1-deficient mice (PD-1-/- mice) nor BALB/c mice 
thymectomized three days after birth (NTx mice), which severely reduces the number of 
naturally arising Foxp3+ regulatory T cells (Tregs) in periphery, developed 
inflammation of the liver. However, PD-1-/- BALB/c mice with neonatal thymectomy 
(NTx–PD-1-/- mice) developed fatal AIH, suggesting that immune dysregulation by a 
concurrent loss of naturally arising Tregs and PD-1–mediated signaling can induce fatal 
AIH. Because of the massive destruction of the parenchyma of the liver, these mice 
started to die as early as two weeks of age, with most dying by four weeks. In humans, 
liver tissue injury in AIH is mediated not only by CD4+ but also by CD8+ T cells.4,5 
Especially in acute-onset human AIH, activated CD8+ T cells are thought to play a 
crucial role in the pathogenesis.6 Fatal AIH in NTx–PD-1-/- mice was characterized by 
CD4+ and CD8+ T-cell infiltration with massive lobular necrosis and huge ANA 
production; activated CD8+ T cells were mainly involved in progression to fatal hepatic 
damage.3 We showed that the infiltrated CD4+ and CD8+ T cells in the severely 
damaged liver produced large amounts of inflammatory cytokines, such as IFN-γ and 
TNF-α. However, it is unclear whether these effector T cells are also crucial in the 
induction phase of the disease. 
 Follicular helper T (TFH) cells are a newly defined effector T cell subset that 
provides powerful help to B cells in forming germinal centers (GCs).7-9 TFH cells arise 
from activated T cells that express Bcl6, a master transcription factor for TFH-cell 
differentiation.8,9 Differentiated TFH cells express IL-21, IL-21 receptor (IL-21R), 
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inducible costimulator (ICOS), CXCR5, and PD-1. IL-21 and ICOS are indispensable 
for TFH-cell generation and helper function to B cells.7-9 CXCR5 promotes the 
colocalization of TFH cells and B cells in GCs.7-9 Although CXCR5+ TFH cells are 
localized mainly in the GC+ B-cell follicles, a recent study showed that circulating T 
cells resembling TFH cells existed in the peripheral blood of patients with B-cell 
mediated autoimmunity.10 In addition, IL-21 has the potential to modulate the activity 
of CD8+ T cells and other immune and non-immune cells in vivo.11 Although AIH 
appears to be a T-cell mediated autoimmune disease, it is characterized by 
hyper-gammaglobulinemia and the production of a variety of circulating autoAbs, 
suggesting that B-cell activation including B-cell mediated autoimmunity is associated 
with its development. Thus, it may be possible that dysregulated TFH cells are involved 
in both T-cell and B-cell mediated autoimmunity in AIH. 
 In this study, using our new mouse model of AIH, we examined the T cell 
subsets responsible for induction of AIH and the mechanisms by which these T cells 
initiate fatal AIH. We found that splenic CD4+ T cells are responsible for induction of 
fatal AIH. In these mice, splenic CD4+ T cells were autonomously differentiated into 
TFH cells. Moreover, dysregulated TFH cells not only promoted ANA production but 
also directly migrated into the liver, triggering the induction of fatal AIH. 
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Materials and Methods 
 All protocols for mice, ELISA, administration of Abs in vivo, histological and 
immunohistological analysis, flow cytometry analysis and isolation of lymphocytes, 
adoptive transfer, real-time quantitative RT-PCR, and T-cell coculture are detailed in 
Supplementary Methods. 
 
 Statistical analysis 
 The data are presented as the mean values ± SD. Statistical analysis was 
performed by the Student t test for pairwise comparisons. Survival rates were estimated 
by the Kaplan-Meier method and compared with the Log-rank test. P-values below .05 
were considered significant. 
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Results 
  
 Splenic CD4+ T cells are responsible for induction of fatal AIH 
 Fatal AIH developed in three-week-old NTx–PD-1-/- mice was characterized 
by severe CD4+ and CD8+ T-cell infiltration.3 To examine whether CD4+ and/or CD8+ T 
cells are indispensable for the development of fatal AIH, NTx–PD-1-/- mice were 
injected intraperitoneally at one day after NTx and then once a week with either 
anti-CD4 or anti-CD8 mAbs. After four injections of anti-CD4 or anti-CD8, the number 
of CD4+ or CD8+ T cells in the periphery was greatly reduced, respectively, and fatal 
AIH was suppressed (Figure 1A and data not shown). Importantly, depletion of CD4+ T 
cells inhibited the infiltration of CD8+ T cells in the liver, whereas depletion of CD8+ T 
cells allowed CD4+ T cells to infiltrate (Figure 1B). These data suggest that both CD4+ 
and CD8+ T cells are indispensable for the development of fatal AIH and that the 
infiltration of CD8+ T cells in the liver is regulated by CD4+ T cells. 
 Three-week-old NTx–PD-1-/- mice with severe AIH showed splenomegaly, 
and the spleen in these mice became enlarged as early as two weeks of age (Figure 1C). 
To determine whether the spleen is an induction site for fatal AIH, we performed 
neonatal splenectomy in these mice. We found that neonatal splenectomy suppressed 
mononuclear infiltration as well as destruction of organ structure in the liver, leading to 
a significantly higher survival rate (Figure 1D and 1E). We had previously 
demonstrated that transfer of total but not CD4+ T-cell depleted splenocytes from 
NTx–PD-1-/- mice into RAG2-/- mice induced the development of severe hepatitis.3 
Taken together, these data suggest that the spleen is an induction site for AIH and that 
splenic CD4+ T cells are responsible for induction of fatal AIH. 
 
 Splenic CD4+ T cells in NTx–PD-1-/- mice are preferentially localized within 
GC-bearing B-cell follicles 
 After the spleen became enlarged at two weeks of age, hepatic damage from 
AIH was apparent at two to three weeks in NTx−PD-1-/-
 
mice.3 When we looked in situ 
at the spleen of two-week-old NTx−PD-1-/-
 
mice, most of the CD4+ T cells were 
preferentially localized within B220+ B-cell follicles, whereas CD8+ T cells were 
mainly localized outside the follicles. Interestingly, B-cell follicles with CD4+ T-cell 
accumulation autonomously developed PNA+ GCs (Figure 1F left lower panels and 
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supplementary Figure 1). Seven days after thymectomy, 1.5-week-old NTx−PD-1-/- 
mice showed scattered accumulation of CD4+ T cells with B220+ B cells in the spleen 
(Figure 2A). Diffuse accumulation of CD4+ T cells in the follicles with GC formation 
developed in the spleen of 2-week-old mice and progressed in 2.5-week-old mice. 
Although GC size was slightly increased in the spleen of three-week-old NTx−PD-1-/- 
mice, localization of CD4+ T cells moved into the marginal region of follicles (Figure 
2A, right panels). 
 The rapid accumulation of CD4+ T cells in the follicles with GC formation 
depended on concurrent loss of naturally arising Tregs and PD-1 mediated signaling, 
because neither PD-1-/- mice nor NTx mice at two weeks of age showed any of these 
phenotypes (Figure 1F), nor did they develop fatal AIH.3 In addition, Foxp3 expression 
of splenic CD4+ T cells of NTx−PD-1-/-
 
mice was severely reduced (Figure 2B), and 





suppressed GC formations in the spleen (Figure 2C and data not shown). On the other 
hand, concomitant administration of blocking mAbs to PD-L1 and PD-L2 induced an 
accumulation of CD4+ T cells in the follicles and development of GCs in the spleen of 
NTx mice at two weeks (Figure 2D). Interestingly, we found that in one of the PD-1 
ligands, PD-L1 mRNA expression was upregulated in the liver of one- to 
three-week-old NTx–PD-1-/- mice (Figure 2E). 
 
 Splenic CD4+ T cells in NTx−PD-1-/-
 
mice display the molecular signature 
of TFH cells and directly induce AIH 
 We next examined whether accumulated CD4+ T cells in the follicles of the 
spleen display the molecular signature of TFH cells. CD4+ T cells in the spleen of 
one-week-old NTx−PD-1-/- mice showed increased IL-21 mRNA expression (Figure 
3A). In addition, CD4+ T cells isolated from the spleen of 2- to 3-week-old NTx−PD-1-/- 
mice also showed increased Bcl-6 and IL-21 mRNA expressions (Figure 3B). Protein 
expressions of Bcl-6, IL-21, ICOS, and CXCR5 were detectable in these cells (Figure 
3C and D upper panels), indicating some key features of TFH cells.7-9 In addition, B220+ 
B cells expressed FAS and GL7 (Figure 3D lower panels), hallmarks of GC B cells.7-9 
Moreover, GC size increased in the spleen of mice aged one to three weeks  
(supplementary Figure 2). Three-week-old NTx−PD-1-/- mice showed 
hyper-gammaglobulinemia and vast production of class-switched ANAs (supplementary 
Aoki et al. 8 
Figure 3). 
 To investigate whether splenic TFH cells directly trigger the development of 
T-cell mediated AIH, we purified ICOS+CD4+ TFH cells or ICOS-CD4+ T cells from the 
spleen of 2.5-week-old NTx–PD-1-/- mice and transferred those T cells into T- and 
B-cell–deficient RAG2-/- mice. In contrast to transfer of ICOS-CD4+ T cells, transfer of 
ICOS+CD4+ TFH cells induced mononuclear cell infiltrations in the portal area of the 
liver and significantly increased serum levels of AST and ALT in recipient mice at three 
weeks after transfer (Figure 3E and 3F). These data suggest that splenic TFH cells in 
NTx–PD-1-/- mice can directly trigger T-cell–mediated AIH. 
 
 Key features of TFH cells, expressions of IL-21 and Bcl6 are sustained in 
splenic and hepatic CD4+ T cells in the development of AIH 
  To further characterize CD4+ T cell subsets in the development of AIH, we 
isolated splenic and hepatic CD4+ T cells from NTx–PD-1-/- mice aged one to three 
weeks and measured expression levels of mRNA encoding master regulators and related 
cytokines for different T-cell subsets. Although not only TFH cells but also Th17 cells 
are reported to express IL-21,12 isolated CD4+ T cells from the spleen and liver showed 
upregulated IL-21 but not IL-17A mRNA expression in NTx−PD-1-/- mice (Figure 4A), 
suggesting these CD4+ T cells are not likely to be a Th17 subset. When we looked at 
master regulators for T-cell subsets, in NTx–PD-1-/- mice at one week, splenic CD4+ T 
cells significantly upregulated mRNA expression of Bcl-6 but not RORγT, GATA-3 or 
T-bet (Figure 4B). In addition, in the induction phase of AIH in NTx–PD-1-/- mice at 
two weeks, not only splenic CD4+ T cells but also hepatic CD4+ T cells significantly 
upregulated mRNA expression of Bcl-6 but not others. Notably, although T-bet 
expression was also significantly upregulated in both splenic and hepatic CD4+ T cells 
in the progression phase of AIH in NTx–PD-1-/- mice at three weeks, upregulated 
expression of Bcl-6 was sustained in those CD4+ T cells. 
 
 Administration of either anti-ICOS or anti–IL-21 completely suppresses not 
only TFH-cell generation but also induction of fatal AIH 
 IL-12 is decisive in the development of Th1 subsets whereas ICOS and IL-21 
are indispensable for TFH-cell differentiation and maturation.7-9 To further examine 
whether differentiation of Th1 and/or TFH subsets is critical in the induction of AIH, we 
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administered blocking mAbs to IL-12p40, ICOS or IL-21. Although production of ANA 
in both IgG1 and IgG2a subclass increased in NTx–PD-1-/- mice (supplementary Figure 
3), injections of anti–IL-12p40 induced reciprocal alteration of ANA in Th1-dependent 
IgG2a and Th2-dependent IgG1 subclasses (supplementary Figure 4). However, the 
neutralization of IL-12 did not significantly reduce the size of GCs in the spleen at four 
weeks (Figure 4C). In contrast, after four injections of either anti-ICOS or anti–IL-21, 
NTx–PD-1-/- mice at four weeks showed markedly suppressed GC formation in the 
spleen and accumulation of CD4+ T cells in the follicles (Figures 4C, 4D and 
supplementary Figures 5A and 6A). In addition, hyper-gammaglobulinemia and ANA 
production, including class-switched Abs, were greatly reduced in those mice 
(supplementary Figure 5C and data not shown). Importantly, although neutralizing 
IL-12 did not suppress AIH development, either anti-ICOS or anti–IL-21 injections 
completely suppressed infiltration of not only CD4+ T cells but also CD8+ T cells in the 
liver as well as liver destruction, resulting in a significantly higher survival rate (Figure 
4D-F and supplementary Figures 5B and 6B). These data suggest a link between 
generation of TFH cells and induction of AIH. 
 
 IL-21 is a key cytokine for not only TFH generation but also activation of 
CD8+ T cells 
Next, we examined how CD4+ T cells help CD8+ T cells in developing AIH. 
In the induction phase in two-week-old mice, CD8+ T cells not only in the liver but also 
in the spleen showed Ki-67high activated T-cell phenotype with highly proliferating 
potential (Figure 5A). IL-21 potentially modulates activity of CD8+ T cells,11 and TFH 
cells in the spleen produced IL-21 (Figure 3A-C and 4A). Moreover, IL-21R mRNA 
expression in splenic CD8+ T cells was elevated in NTx–PD-1-/- mice (Figure 5B). 
Therefore, to examine whether CD4+ T-cell help for CD8+ T-cell activation in the spleen 
depends on IL-21 in the induction phase of AIH, CD8+ T cells were purified from the 
spleen of PD-1-/- mice. These CD8+ T cells were cultured with CD4+ T cells from the 
spleen of two-week-old PD-1-/- mice with or without NTx. After one day of culture, 
CD8+ T cells cultured with CD4+ T cells from NTx–PD-1-/- mice showed a significant 
increase of Ki67+ cells in the CD8+ T-cell population, indicating that activated CD4+ T 
cells in the spleen of NTx–PD-1-/- mice have the potential to induce CD8+ T-cell 
activation (Figure 5C). In addition, neutralizing antibodies to IL-21 suppressed increase 
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of Ki67+ cells in CD8+ T-cell population cultured with those CD4+ T cells, suggesting 
that IL-21 produced by TFH cells drives activation of CD8+ T cells (Figure 5D). 
Moreover, recombinant IL-21 further increased Ki67+CD8+ T cells cultured with those 
CD4+ T cells dose-dependently (Figure 5E). These data suggest that IL-21 is a key 
cytokine for not only TFH generation but also activation of CD8+ T cells in AIH 
development. 
 
 The CCR6-CCL20 axis is crucial for splenic T-cell migration into the liver, 
inducing fatal AIH 
 Finally, to examine how dysregulated TFH cells and activated CD8+ T cells 
migrate from the spleen into the liver in the induction phase of AIH, we analyzed 
chemokine receptor expression of T cells in the spleen and liver by flow cytometry. 
Previously we showed that CD4+ T cells in the spleen and liver expressed chemokine 
receptor CCR6 in NTx−PD-1-/- mice.3 In CD4+ T cells of two-week-old NTx−PD-1-/- 
mice, CCR6+ and, to a lesser extent, CCR9+ cells increased (Figure 6A). The 
predominant increase of CCR6+ cells was observed only at two weeks in the spleen and 
liver but not in mesenteric lymph nodes. In contrast, in three-week-old mice, CXCR3+ 
cells were predominant in splenic and hepatic CD4+ T cells compared with CCR6+ or 
CCR9+ cells (Figure 6B). Splenic CCR6+CD4+ T cells in NTx−PD-1-/- mice contained 
CXCR5+CCR6+ population (Figure 6C left panels), suggesting that these T cells 
retained the molecular signature of TFH cells. In three-week-old mice, CXCR5+CCR6- 
population was further increased whereas the CXCR5+or-CCR6+ population was 
decreased (Figure 6C right panels), suggesting preferential loss of CCR6+ cells from the 
spleen after induction of AIH. In addition to CD4+ T cells, in CD8+ T cells, 
predominant increases of CCR6+ cells in the spleen and liver were also found in the 
induction phase of AIH (Figure 6D and 6E). Moreover, gene expression of CCR6 
ligand CCL20, but not CCR9 ligand CCL25, was elevated in the liver of 1.5- and 
2-week-old NTx−PD-1-/- mice (Figure 6F). These data suggest that CCR6 expressing T 
cells in the spleen may migrate into CCL20-expressing liver and trigger the 
development of fatal AIH. 
 To determine whether the CCR6-CCL20 axis is critical for migration of 
splenic T cells into the liver and triggering fatal AIH, we administered mAbs blocking 
to CCL20. After three injections of anti-CCL20 Abs, the spleen of three-week-old 
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NTx−PD-1-/- mice showed further accumulation of TFH cells in the GC+ follicles 
diffusely (Figure 7A and Figure 7B left panel). These findings contrasted with the 
spleens of non-injected three-week-old NTx−PD-1-/- mice, in which splenic TFH cells 
were mainly localized in the marginal region of follicles (Figure 7A), and with the 
spleens from anti-ICOS or anti–IL-21 injected mice, in which splenic CD4+ T cells 
were greatly reduced (Figure 4D). Importantly, administering anti-CCL20 suppressed 
infiltration of CD4+ and CD8+ T cells into the liver and liver destruction, with a 
significantly increased survival rate at four weeks (Figure 7B right panel, 7C and 7D). 
These data suggest that in the induction phase of AIH, the CCR6-CCL20 axis is crucial 
for migration of dysregulated TFH cells and activated CD8+ T cells from the spleen into 
the liver. 
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Discussion  
 We demonstrated herein that in our mouse model of spontaneous AIH induced 
by a concurrent loss of Tregs and PD-1–mediated signaling, splenic CD4+ T cells are 
crucial in the development of fatal AIH. In the induction phase, splenic CD4+ T cells in 
these mice showed the TFH-cell phenotype, and CCR6-expressing TFH cells and 
activated CD8+ T cells in the spleen preferentially recruited to the liver via CCL20, 
triggering the induction of fatal AIH. 
 We found that CD4+ T cells in the induction site of AIH, the spleen, were 
exclusively localized in GC-bearing B-cell follicles. In the induction phase of AIH, 
these CD4+ T cells upregulated expression of Bcl6, the master transcription factor for 
TFH-cell differentiation, and showed the IL-21+IL-21R+ICOS+CXCR5+ TFH-cell 
phenotype.7-9 In addition, B cells in the spleen contained FAS+GL7+ GC B cells, and 
hyper-gammaglobulinemia, and huge production of class-switched ANAs were 
observed in the serum from NTx−PD-1-/- mice. Moreover, in vivo administration of 
blocking Abs to ICOS or IL-21, indispensable for TFH-cell generation and maturation7-9, 
inhibited accumulation of CD4+ T cells in B-cell follicles and GC formation in the 
spleen, and suppressed hyper-gammaglobulinemia, class-switched ANA production as 
well as induction of AIH. Importantly, adaptive transfer of the splenic TFH cells from 
NTx–PD-1-/- mice directly triggered T-cell–mediated AIH. From these data, we 
concluded that in our mouse model, the responsible CD4+ T-cell subset in the induction 
site of AIH is TFH cells.  
 Previously, we reported that severely inflamed livers in three-week-old 
NTx−PD-1-/- mice contained a massive infiltration of activated CD4+ and CD8+ T cells 
producing inflammatory cytokines, such as IFN-γ and TNF-α.3 In contrast, we found in 
this study that in the induction phase of AIH, IL-21–producing splenic TFH cells were 
responsible for the initiation of liver inflammation. Thus, dysregulated TFH cells and 
Th1-like cells appear to operate at different time points in the development of fatal AIH. 
Recent studies show that although in experimental autoimmune encephalomyelitis 
(EAE), a CD4+ T cell-mediated disease of the central nervous system, Th1 cells are 
present in EAE lesions during its active phase, in its induction phase, Th17 cells directly 
initiate inflammation and trigger the entry of a second wave of Th1 cells that migrate 
into the lesions.13 Because we found upregulation of bcl-6 and t-bet in both splenic and 
hepatic CD4+ T cells of three-week-old NTx−PD-1-/- mice, it might be that in the 
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progression phase of AIH, dysregulated TFH cells directly differentiate into Th1-like 
cells in the spleen and give rise to the migration of a second wave of Th1-like cells into 
the liver. 
 In this mouse model, infiltration of both CD4+ and CD8+ T cells in the liver 
are required for progression to fatal AIH, and the infiltration of CD8+ T cells in the liver 
depends on CD4+ T cells. In the induction phase of AIH, splenic CD8+ T cells showed 
Ki-67high activated T cell phenotype. CD4+ T cells from the spleen of two-week-old 
NTx−PD-1-/- mice induced IL-21−driven CD8+ T-cell activation. In addition, activated 
CD8+ T cells in the spleen expressed CCR6 and were preferentially recruited to the liver 
via CCL20. However, the precise roles of CD8+ T cells in the induction phase of AIH 
are still unclear. Because a large number of CD8+ T cells infiltrated into the liver during 
AIH progression, CD8+ T cells infiltrated in the induction phase might be involved in 
triggering the subsequent expansion and/or infiltration of inflammatory T cells in the 
progression phase. 
 We showed here that the CCR6-CCL20 axis is essential for splenic TFH cells 
to migrate into the liver, triggering inflammation. CCR6 is also expressed on Th17 cells 
and is vital to the initiation of Th17-cell migration to target tissues.13-15 CCR6 is 
expressed on not only Th17 cells but also Tregs in mice,14,15 and human T cells that 
produce both IL-17 and IFN-γ as well as Th1 cells.16 Taken together, these data suggest 
that the CCR6-CCL20 axis plays an important role in the migration of instructed CD4+ 
T cells into target tissues. 
 We also showed that NTx–PD-1-/- mice but not NTx mice at two weeks 
generated TFH cells in the spleen. In addition, concomitant administration of blocking 
mAbs to PD-L1 and PD-L2 generated TFH cells in the spleen of NTx mice at two weeks. 
Moreover, purified CD4+ T cells in the spleen of one-week-old NTx–PD-1-/- mice had 
greater IL-21 mRNA expression than those in NTx mice. In this regard, recent studies 
suggested that PD-1 deficiency increased TFH-cell numbers but reduced IL-21 
production by TFH cells in long-term humoral immunity,17 and that TFH-cell 
differentiation requires strong signals through the T cell receptor.18 Thus, in our model, 
PD-1–deficiency may induce enhanced production of IL-21 by activated autoreactive 
CD4+ T cells to differentiate into TFH cells in the induction phase. On the other hand, we 
found that PD-L1 but not PD-L2 mRNA expression was upregulated in the liver of 
NTx–PD-1-/- mice. Because PD-1 and PD-Ls expressions are increased in the livers of 
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most AIH patients,19,20 it is possible that PD-1/PD-L1 interaction is insufficient to 
completely suppress liver inflammation but may halt progression to fatal AIH. 
 In humans, it is unknown at present whether the spleen is the induction site of 
AIH or TFH cells are the T cell subset responsible for induction of AIH. In patients with 
active AIH, splenomegaly is a common clinical finding. However, splenectomy for 
these patients has not been reported to be therapeutic. Therefore, splenectomy may help 
patients at the early phase of AIH, but not those with more advanced cases. Notably, 
because patients with severe AIH have a high potential for recurrence after liver 
transplantation and the recurrence of AIH leads to a greater probability of graft loss,21,22 
splenectomy might be a therapeutic option to prevent recurrence after liver 
transplantation. On the other hand, it may be that dysregulated TFH cells are involved in 
both B-cell and T-cell mediated autoimmunity in human AIH. Indeed, TFH cells not 
only offer powerful help to B cells in forming germinal centers in humoral immunity 
but also induce B-cell mediated systemic autoimmunity in humans and mice.7-9,23 In 
addition, although TFH cells are mainly localized in B-cell follicles in lymphoid organs, 
circulating T cells resembling TFH cells exist in the peripheral blood of patients with 
systemic lupus erythematosus.10 Furthermore, IL-21 secreted by effector T cells 
including TFH cells can modulate the activity of CD8+ T cells and other immune and 
non-immune cells in humans and mice.11 
  In conclusion, we demonstrated in the present study that Tregs and 
PD-1−mediated signaling are important in regulating TFH cells and that dysregulated 
TFH cells in the spleen are responsible for induction of fatal AIH in NTx−PD-1-/- mice. 
In addition, CCR6-CCL20 axis-dependent migration of TFH cells is crucial for initiation 
of AIH. These data may lead to novel therapeutic approaches to human AIH, especially 
acute-onset fulminant AIH. 
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Figure legends 
Figure 1  
Splenic CD4+ T cells are responsible for induction of fatal AIH. (A and B) 
NTx–PD-1-/- mice were injected intraperitoneally at one day after NTx and then 
once a week with anti-CD4 (n=5), anti-CD8 (n=5), or isotype (n=5) Abs. After 
four injections, mice at four weeks of age were sacrificed and the livers were 
harvested. Survival rate of the mice (A) and stainings of the liver for hematoxylin 
and eosin (HE), CD4 and CD8 at four weeks (B). (C) Macroscopic view of the 
liver and spleen from indicated mice. (D and E) Survival rate (D) and histology of 
the liver (E) from 4-week-old NTx–PD-1-/- mice with (n=7) or without (n=9) 
neonatal splenectomy (NSplx). (F) The spleens from indicated mice at two 
weeks of age were stained with FITC-conjugated anti-CD4, anti-CD8 or PNA 
(green) and biotin-labeled anti-B220 followed by Texas red-conjugated avidin 
(red). Scale bars, 1 cm in (C) and others, 100 µm. *; P < 0.05. 
 
Figure 2 
Autonomous localization of splenic CD4+ T cells within GC+ follicles depends on 
concurrent loss of naturally arising Tregs and PD-1 mediated signaling. (A) The 
spleens from indicated mice at one to three weeks of age were stained as 
described in Figure 1F. (B) Foxp3 mRNA expression by CD4+ T cells from the 
spleen of indicated mice (C) Double immunostainings of the spleen from 
2-week-old NTx–PD-1-/- mice transferred with splenic Tregs from normal BALB/c 
mice. The spleens were stained as Figure 1F. (D) Double immunostainings of 
the spleen in 2-week-old NTx mice injected at days 3 and 10 with anti-PD-L1 and 
anti-PD-L2. The spleens were stained as described in Figure 1F. (E) PD-L1 and 
PD-L2 mRNA expressions of liver and spleen of PD-1-/- mice at indicated age in 
weeks with (closed bars) or without (open bars) NTx. Bars indicate the mean of 
each group, and short bars indicate the SD. *; P < 0.05. N.D.; not detected. All 
scale bars, 100 µm. 
 
Figure 3 
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Splenic CD4+ T cells in NTx–PD-1-/- mice display the molecular signature of TFH 
cells and directly trigger AIH. (A) IL-21 mRNA expressions by isolated splenic 
CD4+ T cells in indicated mice at one week of age. (B) Bcl6 and IL-21 mRNA 
expressions by isolated splenic CD4+ T cells and B220+ B cells in 2.5-week-old 
PD-1-/- mice with (closed bars) or without (open bars) NTx. (C) Double 
immunostainings of isolated splenic CD4+ICOS+ T cells from 2.5-week-old 
NTx–PD-1-/- mice with DAPI and anti-Bcl6, anti–IL-21, or the isotype controls. 
(D) Flow cytometric analysis of CD4+ T cells (upper panels) and B220+ cells 
(lower panels) in indicated mice at two or three weeks of age. The cells were 
stained with indicated Abs as described in Methods. Numbers in plots indicate 
percent cells in each gate. (E and F) CD4+ICOS+ T cells or CD4+ICOS- T cells 
from the spleen of 2.5-week-old NTx–PD-1-/- mice were transferred into RAG2-/- 
mice intravenously. Staining of the liver for HE three weeks after transfer (E). 
Serum levels of the liver transaminase, aspartate aminotransferase (AST), and 
alanine aminotransferase (ALT) (F). Bars indicate the mean of each group, and 
horizontal short bars indicate the SD. *; P < 0.05. N.D.; not detected. Scale bars, 
10 µm in (C) and others, 100 µm. 
 
Figure 4 
TFH-cell generation rather than Th1 differentiation is primarily involved in the 
induction of fatal AIH. (A and B) Splenic and hepatic CD4+ T cells were isolated 
from indicated aged PD-1-/- mice with (closed bars) or without (open bars) NTx. 
Real-time quantitative RT-PCR analysis was performed to measure the 
expression levels of mRNA encoding indicated master regulators for T cell 
subsets and related cytokines. (C-F) NTx–PD-1-/- mice were intraperitoneally 
injected as described in Figure 1B with anti–IL-12p40, anti-ICOS, or anti–IL-21 
Abs. After four injections, mice at four weeks of age were sacrificed and the 
spleens and livers harvested. In Figure 4C, the size of GCs in the spleen of 
indicated mice. Spleens were stained as Figure 1F. Each open circle represents 
a size of GC measured in high-power fields (C). CD4+ T cell numbers in the 
follicles of the spleen (left) or the liver (right) of indicated mice (D). HE staining of 
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the liver and survival rate in NTx–PD-1-/- mice injected with anti–IL-12p40 (n=5) 
or isotype (n=5) Abs (E). Survival rate in NTx–PD-1-/- mice with anti-ICOS (n=5) 
or isotype (n=7) Abs and those with anti–IL-21 (n=5) or isotype (n=5) Abs (F). 
Bars indicate the mean of each group, and short bars indicate the SD. *; P < 
0.05. N.D.; not detected. All scale bars, 100 µm. 
Figure 5 
IL-21 is a key cytokine for CD8+ T-cell activation induced by CD4+ T cells. (A) 
Flow cytometric analysis of cells in the spleen and liver of 2-week-old 
NTx–PD-1-/- mice. Phenotypes of CD3+CD4+ and CD3+CD8+ T cells were shown. 
Filled histograms represent anti-Ki-67 staining; open histograms represent the 
isotype controls. Numbers indicate percent of Ki67+ cells. Data represent one of 
three separate experiments. (B) IL-21R mRNA expressions by isolated CD4+, 
CD8+ T cells, and B220+ B cells of the spleen and liver in 2.5-week-old PD-1-/- 
mice with (closed bars) or without (open bars) NTx. Bars indicate the mean of 
each group, and horizontal short bars indicate the SD. (C-E) Flow cytometric 
analysis of CD8+ T cells. CD8+ T cells were purified from the spleen of PD-1-/- 
mice and then cultured with CD4+ T cells from the spleen of two-week-old PD-1-/- 
mice with or without NTx. After one day of culture with indicated conditions, 
percent of Ki67+ cells in CD8+ T-cell population was determined by flow 
cytometry. Bars indicate the mean of triplicated wells of each group, and 
horizontal short bars indicate the SD. *; P < 0.05. 
 
Figure 6 
CCR6+ cells are predominantly increased in CD4+ and CD8+ T cells in the spleen 
and liver only in the induction phase of AIH. (A-E) Cells in the spleen, liver and 
mesenteric lymph nodes (MLN) of NTx–PD-1-/- mice at the indicated age were 
stained with FITC-anti-CD3e, APC-Cy7-anti-CD4 and PE-anti-CCR6, 
-anti-CCR9, or -anti-CXCR3 (A, B and D upper panles), with FITC-anti-CXCR5, 
PE-anti-CCR6, and APC-Cy7-anti-CD4 (C), or with FITC-anti-CD3e, 
PE-anti-CCR6 APC-anti-CD8 (D lower panels and E). Flow cytometric analyses 
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were assessed as in Figure 3D. Numbers of indicated T cell populations were 
calculated by (percentage of the cells in viable cells) x (no. of viable cells) (A, B, 
C right panels, and E). Numbers indicate percent of indicated gates (C left 
panels, D). (F) CCL20 or CCL25 mRNA expressions in the spleen and liver of 
PD-1-/- mice at indicated age with (closed bars) or without (open bars) NTx. Bars 




The CCR6-CCL20 axis plays a crucial role for both migration of splenic TFH cells 
into the liver and induction of fatal AIH. (A-D) NTx–PD-1-/- mice were injected 
intraperitoneally as described in Figure 1 with anti-CCL20 (n=10) or isotype 
(n=10) Abs. The spleen and liver were stained as in Figure 1B and 1F. Double 
immunostainings of the spleen of 3-week-old mice (A). CD4+ T cell numbers in 
the follicles of the spleen of 3-week-old (left) and in the liver of 4-week-old (right) 
of indicated mice (B). Immunostainings for CD4, and CD8, and HE staining of 
the liver of 4-week-old mice (C). Survival rate of each group of 4-week-old mice 
(D). Bars indicate the mean of each group and horizontal short bars indicate the 
















 BALB/c mice were purchased from Japan SLC (Shizuoka, Japan), and 
PD-1-/- and RAG-2-/- mice on a BALB/c background were generated as described.1,2 
All of these mice were bred and housed under specific pathogen-free conditions. 
Thymectomy and splenectomy of the mice three days after birth were performed as 
described.3,4 All mouse protocols were approved by the Institute of Laboratory 
Animals, Graduate School of Medicine, Kyoto University. 
ELISA 
 Serum Ig levels were determined by ELISA as described,5 and Ab sets for 
detection of mouse IgG1, IgG2a, IgG2b, IgG3, IgA, and IgE from BD Biosciences 
(San Jose, CA) and anti-mouse IgM from AbD Serotec (Oxford, UK) were used. To 
detect serum ANAs, microtiter plates (Nunc, Roskilde, Denmark) were incubated 
with 10 µg/ml antigens, and the nuclear fraction was prepared from normal liver.6 Ab 
sets for detection of mouse ANA subclasses were the same as above. 
 Administration of Abs in vivo 
 NTx−PD-1-/- mice at one day after thymectomy were intraperitoneally 
injected every week with 100 µg of Abs. Anti-CD4 (RM4-5) and anti-CD8 (53-6.7) 
for depletion of CD4+ T cells and CD8+ T cells, respectively, and neutralizing Abs to 
mouse ICOS (7E.17G9) were from eBioscience (San Diego, CA). Neutralizing Abs to 
mouse IL-21 (AF594), IL-12p40 (C17.8) as well as CCL20 (114908) were from R&D 
Systems (Minneapolis, MN). Neutralizing Abs to mouse PD-L1 and PD-L2 were 
purified from ascites as described.7 All isotypes were from eBioscience or R&D 
Systems. After two to four injections, mice at two to four weeks of age were 
sacrificed, and their spleens and livers were harvested.  
 Histological and immunohistological analysis 
 Organs were fixed in neutral buffered formalin and embedded in paraffin 
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wax. Sections were stained with hematoxylin and eosin for histopathology. 
Fluorescence immunohistology was performed on frozen sections as described 
previously3 using FITC-conjugated anti-CD4 (RM4-5), anti-CD8a (Ly-2) 
(eBioscience), peanut agglutinin (PNA, Vector Laboratories, Burlingame, CA), 
biotin-labeled anti-B220 (RA3-6B2) (BD Biosciences) followed by Texas 
red-conjugated avidin (Vector Laboratories). Numbers of CD4+ T cells localized 
within B220+ B-cell follicles in the spleen and inflamed liver were counted in several 
high-power fields in at least three sections of each mouse. Diameter of GCs was 
measured in several high-power fields in at least three sections of each mouse. 
Single-cell suspensions of isolated splenic CD4+ICOS+ T cells from 2.5-week-old 
NTx–PD-1-/- mice were mounted on glass slides by cytocentrifuge preparation. After 
fixation, these cells were stained with anti-Bcl6 (N3) (Santa Cruz Biotechnology, 
Santa Cruz, CA) followed by FITC-conjugated goat anti-rabbit Ig (BD Biosciences), 
or anti–IL-21 (AF594) (R&D Systems) followed by FITC-conjugated rabbit anti-goat 
Ig (ab6737) (Abcam, Cambridge, MA), and DAPI (Sigma-Aldrich, St. Louis, MO). 
Rabbit IgG isotype (DA1E) and normal goat IgG isotype (AB-108-C) were from Cell 
Signaling (Danvers, MA) and from R&D Systems, respectively. 
 Flow cytometry analysis and isolation of lymphocytes 
 Single cells from the livers and spleens were prepared as described.3 The 
following mAbs were used for staining: FITC-conjugated anti-CD3e (145-2C11), 
anti-CD8a (eBioscience); anti-CXCR5 (2G8), anti-GL7, anti-Ki67 (B56) (BD 
Biosciences); PE-conjugated anti-CD3e, anti-CD4, anti-CD25 (PC61.5), anti-ICOS 
(eBioscience); anti-B220, anti-CD95/Fas (Jo2) (BD Biosciences); anti-CCR6 
(140706), anti-CCR9 (242503), anti-CXCR3 (220803) (R&D Systems); 
APC-Cy7-conjugated anti-CD4 (GK1.5), biotin-labeled B220 (BD Biosciences); and 
APC-conjugated streptavidin, and anti-CD8a (eBioscience). In flow cytometric 
analysis of CD4+ T cells and B220+ B cells in Figure 3, cells were stained with 
FITC-anti-CXCR5, PE-anti-ICOS, and APC-Cy7-anti-CD4 for CD4+ T cells; or with 
FITC-anti-GL7, PE-anti-CD95/Fas, and biotin-labeled B220 followed by 
APC-conjugated streptavidin for B220+ B cells. For Ki-67 antigen staining in Figure 5, 
a FITC-conjugated Ab set (BD Bioscience) was used with PE-anti-CD3 and 
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APC-Cy7-anti-CD4 or APC-anti-CD8. In flow cytometric analysis of T cells in 
Figure 6, cells were stained with FITC-anti-CD3e, PE-anti-CCR6, -anti-CCR9, or 
-anti-CXCR3 and APC-Cy7-anti-CD4, with FITC-anti-CXCR5, PE-anti-CCR6, and 
APC-Cy7-anti-CD4, or with FITC-anti-CD3e, PE-anti-CCR6, and APC-anti-CD8. 
Stained cells were analyzed with a FACSCantoTM II (BD Biosciences). Data were 
analyzed using Cell Quest ProTM (BD Biosciences). Dead cells were excluded on the 
basis of side- and forward-scatter characteristics, and viable T cell numbers were 
calculated as follows: (the percentage of cells in the cell type) x (the number of viable 
cells). CD3+CD4+, CD3+CD8+, CD3-B220+ cells from the spleen or liver, and 
CD4+ICOS+, CD4+ICOS- T cells and CD4+CD25+ Tregs from the spleen were 
obtained by a FACS AriaTMII (BD Biosciences) to reach >99% purity, as described.3 
 Adoptive transfer 
  CD4+CD25+ Tregs prepared from the spleen of adult BALB/c PD-1+/+ or 
PD-1-/-
 
mice as described.3 Tregs (1x106) were intraperitoneally injected into 
NTx−PD-1-/- mice at one day after thymectomy. For transfer of TFH cells or non-TFH 
cells, CD4+ICOS+ T cells or CD4+ICOS- T cells, respectively were prepared from the 
spleen of 2.5-week-old NTx–PD-1-/-
 
mice as described above. Isolated T cells (1x106) 
were intravenously injected into RAG2-deficient recipient mice on a BALB/c 
background at 4 weeks of age. Three weeks after transfer, recipient mice were 
examined. 
 Real-time quantitative RT-PCR 
 Real-time quantitative RT-PCR was performed as described previously.8 
Spleen and liver tissues or isolated lymphocytes were frozen in RNAlater. RNA was 
prepared with an RNeasy mini kit (Qiagen, Hilden, Germany), and single-strand 
cDNA was synthesized with SuperScript II reverse transcriptase (Invitrogen, Carlsbad, 
CA).  Real-time quantitative RT-PCR was performed using SYBR Green I Master 
(Roche Applied Science, Basel, Switzerland). The real-time quantitative reactions 
were performed using a Light CyclerTM 480 (Roche Applied Science) according to the 
manufacturer’s instructions. Values are expressed as arbitrary units relative to 
GAPDH. The following primers were used: GAPDH: 





5’-GCATGTTCTGGAATGCTCAC-3’ and 5’-CTTTGGGTTCCATCCGACT-3’; 






5’-AGTGACCCCGTCATCTTTCA-3’ and 5’-AGGAGCAGCAGCATGTGAG-3’; 






5’-TTATCAAGCCCAAGCGAAG-3’ and 5’-TGGTGGTGGTCTGACAGTTC-3’; 
CCL20: 5’-ATGGCCTGCGGTGGCAAGCGTCT-3’ and 
5’-TAGGCTGAGGAGGTTCACAGCCC-3’; CCL25: 
5’-GAGTGCCACCCTAGGTCATC-3’ and 5’-CCAGCTGGTGCTTACTCTGA-3’.  
 T-cell coculture 
 CD4+ and CD8+ T cells were isolated from the spleen of 2-week-old PD-1-/- 
mice with or without NTx using a FACS AriaTMII (BD Biosciences) to reach >99% 
purity, as described.3 Isolated CD8+ T cells (5×105) were cocultured with 5×105 
freshly isolated CD4+ T cells in round-bottomed 96-well culture plates in D-MEM 
supplemented with 10% fetal bovine serum, 50 mmol/L 2-mercaptoethanol, 100 U/ml 
penicillin, and 100 µg/ml streptomycin. In some experiments, we used the following 
reagents in these culture conditions: 10 µg/ml of anti–IL-21 (AF594), 10 µg/ml of 
goat IgG isotype, and 1-100 ng/ml of recombinant IL-21 (all from R&D Systems). 
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After 24 hours of culture, cells were stained with PE-anti-CD3, APC-anti-CD8, and 
FITC-anti-Ki67 or -isotype control and analyzed with a FACSCantoTM II. 
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Supplementary Data 
Supplementary Figure 1. 
Splenic CD4+ T cells are preferentially localized within B220+ B-cell follicles in 
the induction phase of AIH in NTx–PD-1-/- mice. The spleens from 2-week-old 
NTx–PD-1-/- mice were stained with biotin-labeled anti-B220 and 
FITC-conjugated anti-CD4 followed by Texas red-conjugated avidin. A scale bar, 
100 µm. 
 
Supplementary Figure 2. 
The size of GCs is increased in the spleen of NTx–PD-1-/- mice from one to three 
weeks of age. Spleens from NTx–PD-1-/- mice at the indicated age in weeks 
were stained with FITC-conjugated PNA and biotin-labeled anti-B220 followed 
by Texas red-conjugated avidin. Each open circle represents a size of GC as 
measured in high-power fields. Horizontal bars indicate the mean size (diameter) 
of GCs in at least three sections. Horizontal short bars indicate the SD. *; P < 
0.05. 
Supplementary Figure 3. 
Three-week-old NTx–PD-1-/- mice show hyper-gammaglobulinemia and vast 
production of class-switched anti-nuclear antibodies (ANAs). The serum levels 
of total Ig subclasses and ANAs in IgM, IgG1, and IgG2a of 3-week-old PD-1-/- 
mice with (closed bars) or without (open bars) NTx determined by ELISA. Bars 
indicate the mean of each group, and horizontal short bars indicate the SD. *; P 
< 0.05. 
Supplementary Figure 4.  
Administration of anti–IL-12p40 induces increase of IgG1 and decrease of IgG2a 
classes of anti-nuclear antibodies (ANAs). NTx–PD-1-/- mice were injected 
intraperitoneally at one day after NTx and then once a week with anti–IL-12p40 
(n=5) Abs. After four injections, mice at four weeks of age were sacrificed, and 
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the serum levels of ANAs in IgG1 and IgG2a were determined by ELISA. Bars 
indicate the mean of NTx–PD-1-/- with or without administration of anti–IL-12p40, 
and horizontal short bars indicate the SD. *; P < 0.05. 
Supplementary Figure 5. 
Administration of anti-ICOS suppresses not only TFH-cell generation but also 
induction of fatal AIH, including hyper-gammaglobulinemia and vast production 
of class-switched anti-nuclear antibodies (ANAs). (A-C) NTx–PD-1-/- mice were 
injected intraperitoneally at one day after NTx and then once a week with either 
anti-ICOS (n=5) or isotype (n=7) Abs. After four injections, mice at four weeks of 
age were sacrificed and the spleens and livers harvested. Double 
immunostainings of the spleen. The spleens from indicated mice were stained 
with FITC-conjugated anti-CD4, or PNA (green) and biotin-labeled anti-B220 
followed by Texas red-conjugated avidin (red) (A). Stainings of the liver for 
hematoxylin and eosin (HE), CD4, and CD8 (B). The serum levels of total Ig 
subclasses and ANAs in IgM, IgG1, and IgG2a were determined by ELISA (C). 
Bars indicate the mean of indicated each group, and horizontal short bars 
indicate the SD. *; P < 0.05. All scale bars, 100 µm. 
Supplementary Figure 6. 
Administration of anti–IL-21 suppresses not only TFH-cell generation but also 
induction of fatal AIH. NTx–PD-1-/- mice were injected intraperitoneally at one 
day after NTx and then once a week with either anti-IL-21 (n=5) or isotype (n=5) 
Abs. After four injections, mice at four weeks of age were sacrificed and the 
spleens and livers were harvested. (A) Double immunostainings of the spleen. 
The spleens from indicated mice were stained with FITC-conjugated anti-CD4, 
or PNA (green) and biotin-labeled anti-B220 followed by Texas red-conjugated 
avidin (red). (B) Stainings of the liver for hematoxylin and eosin (HE), CD4 and 
CD8. All scale bars, 100 µm. 
 
 




